Markel Corporation — Q1 2022 Form 10-Q
Business context and reporting period. The filing covers the three months ended March 31, 2022, with balance-sheet comparisons to December 31, 2021. Markel operates specialty insurance and reinsurance, investments, and Markel Ventures businesses. Results are unaudited and interim results are not necessarily indicative of full-year performance.
Financial performance
| Metric | Q1 2022 | Q1 2021 / comparison |
|---|---|---|
| Total operating revenues | $2.606 billion | $2.900 billion; down 10% |
| Operating income (loss) | $(42.1) million | $745.4 million |
| Net income (loss) to common shareholders | $(52.8) million; $(6.58) per diluted share | $573.7 million; $42.02 diluted EPS |
| Net cash from operating activities | $414.9 million | $318.1 million |
| Underwriting profit | $197.0 million; combined ratio 88.8% | $91.0 million; combined ratio 93.9% |
| Net investment income | $72.7 million | $96.6 million |
| Net investment gains (losses) | $(358.4) million | $526.9 million |
Revenue and earnings comparisons were heavily affected by equity-market movements: Q1 2022 included investment losses, versus substantial investment gains in Q1 2021. Net unrealized losses on available-for-sale investments were $603.4 million before tax, contributing to comprehensive loss to shareholders of $529.0 million, compared with comprehensive income of $359.0 million a year earlier. Book value per common share fell 4% from $1,036.20 at year-end to $995.53.
Underwriting. Earned premiums increased 17% to $1.760 billion. The Insurance segment earned $187.5 million of underwriting profit (combined ratio 87.3%); Reinsurance earned $13.3 million (95.3%). Favorable prior-year reserve development was $96.3 million, versus $90.9 million in Q1 2021. Reported consolidated underwriting results included $35.0 million of net Russia-Ukraine conflict losses and $12.3 million of related reinstatement premiums. Excluding current-year catastrophes, the conflict and COVID-19, the combined ratio was 86.8%, versus 88.4%.
Markel Ventures. Revenue rose 35% to $950.4 million, supported by acquisitions and higher demand and prices. Operating income declined 3% to $49.7 million, while EBITDA increased 18% to $95.7 million. Management cited higher materials, labor, shipping and inflation costs, which partly offset revenue growth.
Financial position, liquidity and debt
- Total assets were $49.0 billion at March 31, 2022; total equity was $14.1 billion, down from $14.7 billion at year-end.
- Investments totaled $23.0 billion. Cash and cash equivalents were $3.9 billion, restricted cash was $1.3 billion, and total invested assets including investments and cash were approximately $28.3 billion.
- Debt was $4.43 billion, compared with $4.36 billion at December 31, 2021. The debt-to-capital ratio was 24%, up from 23%. The $300 million corporate revolving facility had no borrowings; Markel Ventures subsidiaries had $213.3 million outstanding on their facilities. The company reported compliance with debt covenants.
- Operating cash flow increased to $414.9 million. Cash, cash equivalents and restricted cash together ended the quarter at $5.21 billion. Investing cash outflow was $50.0 million and financing cash outflow was $18.9 million.
Material changes, outlook and risks
- Investments and interest rates: Management attributed fixed-maturity fair-value declines to rising interest rates and equity losses to unfavorable market movements. Gross unrealized losses on available-for-sale securities rose to $308.0 million from $63.2 million at year-end. Markel said it did not intend, and did not believe it would be required, to sell the securities before recovery; it reported no allowance for credit losses.
- Russia-Ukraine conflict: Gross losses were estimated at $105.0 million, ceded losses at $70.0 million and net losses at $35.0 million. Management said further losses were likely and estimates remained highly uncertain; reserve changes, additional losses or reinsurance costs could be material.
- CATCo transaction: Markel completed a run-off buy-out, recording $101.9 million of net expense and providing $45.1 million of cash funding plus $142.7 million of tail-risk cover. Markel now bears exposure to adverse development on specified legacy reserves.
- Dispositions: Markel sold most of its interest in Velocity for $181.3 million cash and recognized a $107.3 million gain. It had agreed to sell its controlling interest in Volante for expected consideration of $155 million; closing was expected in Q3 2022, subject to approvals and customary conditions.
- Other uncertainties: Management highlighted inflation, social and economic claims inflation, catastrophe exposure, reserve estimation, reinsurance recoverability and market volatility. It reported no quantitative earnings guidance. Management said it believed liquidity was adequate for capital and operating needs.
- Capital allocation and accounting: A new $750 million share repurchase authorization replaced the prior program; $79.3 million of shares were repurchased during the quarter. Markel also changed its policy for deferring certain insurance acquisition salaries and benefits, recording a $22.3 million increase to opening retained earnings; it said the correction was immaterial to previously issued statements.
Important facts for investors to verify
- How equity-market performance, interest rates and investment income affect earnings, accumulated other comprehensive income and book value.
- Whether Russia-Ukraine claims, reinsurance recoveries and reinstatement premiums develop materially beyond current estimates.
- Reserve adequacy, including favorable prior-year development, and the collectability of significant reinsurance recoverables.
- CATCo legacy reserve exposure and the ultimate cost or recovery under its tail-risk cover and buy-out arrangements.
- Whether Volante’s planned sale closes on the expected terms and timing, and how inflation and acquisition costs affect Markel Ventures margins.